Skip to main content

GenVault Secures $10M in Series A

NEW YORK, March 24 - DNA archiving startup GenVault said today that it has received $10 million in a Series A round of financing from Domain Associates.


GenVault is developing a room-temperature DNA archive system that pairs DNA samples with clinically relevant information. The Carlsbad, Calif.-based company said it is targeting the system toward the pharmacogenomics, diagnostics, forensics, and agricultural testing markets.


GenVault said it intends to use the new funding to advance its technology from beta testing to full commercialization by the summer.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.